BioCentury | Dec 21, 2009
Clinical News

DuraTech BioRegeneration Matrix regulatory update

...Osteotech submitted a 510(k) application to FDA for its DuraTech BioRegeneration Matrix to repair or replace the dura...
...procedures. The product is an engineered human collagen biomaterial. Osteotech Inc. (NASDAQ:OSTE), Eatontown, N.J. Product: DuraTech BioRegeneration Matrix...
BioCentury | Jul 6, 2009
Finance

2H09 Milestones

...Co. Ltd. (Osaka:4552) Prochymal Acute graft-versus-host disease (GvHD) Ph III data 3Q09 Osteotech Inc. (NASDAQ:OSTE) DuraTech BioRegeneration Matrix...
BioCentury | Jun 15, 2009
Clinical News

DuraTech BioRegeneration Matrix: Pivotal trial completed enrollment

...pivotal trial comparing DuraTech BioRegeneration Matrix vs. historical surgical procedure outcomes. Osteotech Inc. (NASDAQ:OSTE), Eatontown, N.J. Product: DuraTech BioRegeneration Matrix...
BioCentury | Jan 12, 2009
Finance

2009 milestones

...Osaka:4552) Prochymal Graft-versus-host disease (GvHD) Ph III data; complete rolling BLA submission 2009 Osteotech (NASDAQ:OSTE) DuraTech BioRegeneration Matrix...
BioCentury | Jan 12, 2009
Clinical News

DuraTech BioRegeneration Matrix: Pivotal trial started

...DuraTech BioRegeneration Matrix vs. historical surgical procedure outcomes in 60 patients. Osteotech Inc. (NASDAQ:OSTE), Eatontown, N.J. Product: DuraTech BioRegeneration Matrix...
Items per page:
1 - 5 of 5